SGAM
Smith Group Asset Management Portfolio holdings
AUM
$1.53B
1-Year Return
38.67%
This Quarter Return
+16.25%
1 Year Return
+38.67%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.73B
AUM Growth
-$187M
(-9.7%)
Cap. Flow
-$411M
Cap. Flow
% of AUM
-23.77%
Top 10 Holdings %
Top 10 Hldgs %
38.99%
Holding
343
New
37
Increased
19
Reduced
205
Closed
33
Top Buys
| 1 |
Coherent
COHR
|
$25.7M |
| 2 |
Arrow Electronics
ARW
|
$19.8M |
| 3 |
Thermo Fisher Scientific
TMO
|
$15M |
| 4 |
DaVita
DVA
|
$13.1M |
| 5 |
International Paper
IP
|
$12.3M |
Top Sells
| 1 |
Apple
AAPL
|
$49.1M |
| 2 |
Microsoft
MSFT
|
$36.4M |
| 3 |
Amazon
AMZN
|
$29.2M |
| 4 |
Akamai
AKAM
|
$21.3M |
| 5 |
Centene
CNC
|
$21.3M |
Sector Composition
| 1 | Technology | 37.84% |
| 2 | Consumer Discretionary | 16.07% |
| 3 | Healthcare | 13.89% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 8.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Cactus
WHD
$2.93B
| $215K | 0.01% |
+8,260
| New | +$215K |
|
|
RVLP
177
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $214K | 0.01% |
51,890
-130
| -0.2% | -$536 |
|
178
BridgeBio Pharma
BBIO
$10.2B
| $213K | 0.01% |
2,990
-10
| -0.3% | -$712 |
|
|
BPMC
179
DELISTED
Blueprint Medicines
BPMC
| $209K | 0.01% |
1,860
| – | – |
|
180
Louisiana-Pacific
LPX
$6.9B
| $207K | 0.01% |
5,570
+2,880
| +107% | +$107K |
|
181
EXL Service
EXLS
$7.23B
| $202K | 0.01% |
11,850
-50
| -0.4% | -$852 |
|
|
MDP
182
DELISTED
Meredith Corporation
MDP
| $198K | 0.01% |
+10,330
| New | +$198K |
|
183
Halozyme
HALO
$8.69B
| $190K | 0.01% |
4,440
| – | – |
|
184
TG Therapeutics
TGTX
$5.14B
| $183K | 0.01% |
3,510
-10
| -0.3% | -$521 |
|
185
HealthStream
HSTM
$834M
| $173K | 0.01% |
7,940
-20
| -0.3% | -$436 |
|
|
NVTA
186
DELISTED
Invitae Corporation
NVTA
| $168K | 0.01% |
4,030
| – | – |
|
187
Meritage Homes
MTH
$5.92B
| $162K | 0.01% |
3,920
-20
| -0.5% | -$827 |
|
|
POLY
188
DELISTED
Plantronics, Inc.
POLY
| $156K | 0.01% |
+5,780
| New | +$156K |
|
189
Apellis Pharmaceuticals
APLS
$3.6B
| $148K | 0.01% |
2,580
-10
| -0.4% | -$574 |
|
190
Kforce
KFRC
$599M
| $148K | 0.01% |
3,510
-10
| -0.3% | -$422 |
|
|
LMNX
191
DELISTED
Luminex Corp
LMNX
| $143K | 0.01% |
6,200
-10
| -0.2% | -$231 |
|
|
BHVN
192
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $141K | 0.01% |
1,650
-10
| -0.6% | -$855 |
|
193
Sanmina
SANM
$6.46B
| $138K | 0.01% |
4,340
| – | – |
|
|
ALLK
194
DELISTED
Allakos
ALLK
| $134K | 0.01% |
960
| – | – |
|
195
Insmed
INSM
$30.5B
| $134K | 0.01% |
4,030
| – | – |
|
196
PTC Therapeutics
PTCT
$4.57B
| $132K | 0.01% |
2,170
| – | – |
|
197
KB Home
KBH
$4.63B
| $131K | 0.01% |
3,920
-10
| -0.3% | -$334 |
|
198
Berkshire Hathaway Class B
BRK.B
$1.08T
| $130K | 0.01% |
560
-19
| -3% | -$4.41K |
|
199
Emergent Biosolutions
EBS
$405M
| $129K | 0.01% |
1,440
-10
| -0.7% | -$896 |
|
200
CareDx
CDNA
$731M
| $120K | 0.01% |
1,650
| – | – |
|